PIONEER-PEDS1-H8H-MC-LAHV(a): Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine

Grants and Contracts Details

StatusActive
Effective start/end date3/2/221/24/24

Funding

  • Eli Lilly and Company: $28,550.00